-
In late May 2026, DA Davidson reaffirmed its positive analyst rating on Crane Co and added the company to its selective Best-of-Breed Bison List, while director James L. L. Tullis converted 1,226 Deferred Stock Units into common shares as part of a compensation-related settlement.
-
This combination of strong external analyst endorsement and routine insider equity activity highlights how both market perception and board-level alignment are shaping views of Crane's long-term positioning.
-
We'll now examine how Crane's inclusion in DA Davidson's Best-of-Breed Bison List interacts with its existing investment narrative and outlook.
We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
Crane Investment Narrative Recap
To own Crane, you need to be comfortable with a focused, engineering‑led industrial company that leans on acquisitions, aerospace exposure, and process industries for growth, while managing cyclical swings and integration risk. DA Davidson's Best‑of‑Breed Bison List inclusion and the latest director equity conversion look supportive for sentiment, but they do not materially change near term catalysts or key risks around PFT demand, acquisitions, or end‑market cyclicality.
The most relevant recent announcement is Crane's reaffirmed 2026 guidance, which calls for low to mid 20 percent total sales growth, with core growth in the mid single digits and a large acquisition contribution. That outlook ties directly into the market's focus on whether Crane can successfully integrate the PSI/Druck/Panametrics/Reuter‑Stokes portfolio and realize the efficiency, pricing, and margin benefits that underpin its current investment case.
Yet against this more constructive view, investors should be aware that concentrated exposure to aerospace and PFT could leave Crane more vulnerable if ...
Read the full narrative on Crane (it's free!)
Crane's narrative projects $3.3 billion revenue and $513.3 million earnings by 2029.
Uncover how Crane's forecasts yield a $219.67 fair value , a 18% upside to its current price.
Exploring Other Perspectives
Before this news, the most optimistic analysts expected Crane's revenue to reach about US$3.3 billion and earnings around US$550 million, which is far more upbeat than consensus and assumes smoother integration and stronger demand than the core risk narrative suggests, so it is worth comparing these different views as you think about how fresh analyst endorsements and insider moves might reshape expectations from here.
Explore 3 other fair value estimates on Crane - why the stock might be worth as much as 28% more than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
-
A great starting point for your Crane research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
-
Our free Crane research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Crane's overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
Our top stock finds are flying under the radar-for now. Get in early:
-
The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
-
AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early.
-
This technology could replace computers: discover 29 stocks that are working to make quantum computing a reality .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CR .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
